Skip to main content
. 2010 Oct 14;59(11):1527–1534. doi: 10.1136/gut.2010.216135

Figure 3.

Figure 3

Progression-free survival (A) and progression-free survival in second line. (B) According to treatment arm (Kaplan–Meier estimation); intent to treat population. LV5FU2-CDDP arm: 5-fluorouracil, folinic acid and cisplatin combination followed by gemcitabine. Gemcitabine arm: gemcitabine followed by LV5FU2-CDDP.